CAS 2079108-44-2

Retifanlimab

CAS: 2079108-44-2

Retifanlimab

Reinheit: ≥95%

Ref: 54-BUP20024

Retifanlimab

CAS: 2079108-44-2

Retifanlimab (MGA-012) is a monoclonal antibody targeting programmed cell death protein 1 (PD-1). Retifanlimab is used in studies of Merkel cell carcinoma.

Reinheit: 98.56% (SEC-HPLC) - >95.0% (SDS-PAGE); 100% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 148.28 kDa

Ref: TM-T77180

Retifanlimab

CAS: 2079108-44-2

Anti-Programmed cell death protein 1 (PD-1) monoclonal antibody; treatment of Merkel cell carcinoma

Ref: 3D-CLA1605